StockClub
CSWYFChina Shineway Pharmaceutical Group Limited$ --
China Shineway Pharmaceutical Group Limited

China Shineway Pharmaceutical Group Limited

CSWYF

$ -

-

You can review earnings summary, quarterly trends, full-year progress, and detailed income statement data.

analyticsIncome Statement Summary

FY2024 Full YearUpdated: 12/31/2024

Revenue

attach_money
3,778M CNY
YoY -16.4%

Operating Income

bar_chart
843M CNY
YoY -13.6%

Net Income

verified
840M CNY
YoY +512.5%

EPS

pie_chart
1.11CNY
YoY +516.7%

Quarterly Performance

Quarterly revenue and net income trend

RevenueOperating IncomeNet Income
No quarterly data available

Full-Year Progress

FY2024
Net Income Progress91.2%Below Target
Revenue Progress3.8B
Revenue Forecast4.4B
Net Income Progress840.1M
Net Income Forecast921.3M

Income Statement Details

Item
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Revenue
Cost of revenue
Gross profit
3,778
946
2,832
Research & development
Selling & marketing
Selling, general and administrative
Other operating expenses
Operating income
101
1,597
1,889
2,935
843
Interest expense
Income before tax
Income tax expense
Net income
6
1,146
306
840

Unlock Long-Term Income Statement Data

Your current plan allows viewing financial data for the latest 1 year (annual only). Upgrade to the Standard Plan to view up to 3 years (including quarterly data), or the Premium Plan to access all historical data.